IDE
Basic information
Region (hg38): 10:92451684-92574096
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the IDE gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 44 | 45 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 44 | 3 | 2 |
Variants in IDE
This is a list of pathogenic ClinVar variants found in the IDE region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-92455608-T-C | not specified | Likely benign (Dec 02, 2021) | ||
10-92456365-C-A | not specified | Uncertain significance (Nov 17, 2022) | ||
10-92456389-C-T | not specified | Uncertain significance (Apr 13, 2022) | ||
10-92461235-A-G | not specified | Uncertain significance (Aug 17, 2022) | ||
10-92463758-T-C | not specified | Uncertain significance (Dec 20, 2023) | ||
10-92463774-T-G | not specified | Uncertain significance (Nov 15, 2021) | ||
10-92463846-G-C | not specified | Uncertain significance (Mar 19, 2024) | ||
10-92463969-A-G | Benign (Jul 04, 2018) | |||
10-92465747-A-G | not specified | Uncertain significance (May 13, 2024) | ||
10-92465791-G-T | Benign (Mar 30, 2018) | |||
10-92465811-C-T | not specified | Uncertain significance (May 04, 2022) | ||
10-92468939-G-A | not specified | Uncertain significance (Feb 21, 2024) | ||
10-92468974-A-G | not specified | Uncertain significance (Nov 08, 2022) | ||
10-92468981-C-G | not specified | Uncertain significance (Dec 03, 2021) | ||
10-92468990-C-T | not specified | Uncertain significance (Apr 15, 2024) | ||
10-92470313-G-A | not specified | Uncertain significance (Feb 28, 2023) | ||
10-92470321-G-C | not specified | Uncertain significance (Jan 04, 2022) | ||
10-92475918-A-G | not specified | Uncertain significance (Feb 21, 2024) | ||
10-92475975-T-C | not specified | Uncertain significance (Jun 07, 2023) | ||
10-92475982-C-G | not specified | Uncertain significance (Jun 18, 2024) | ||
10-92479332-G-A | not specified | Uncertain significance (Feb 13, 2023) | ||
10-92479353-G-A | not specified | Uncertain significance (Nov 18, 2022) | ||
10-92483287-C-A | not specified | Uncertain significance (Aug 02, 2023) | ||
10-92487200-A-G | not specified | Uncertain significance (Jun 13, 2023) | ||
10-92487221-G-A | not specified | Uncertain significance (Mar 29, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
IDE | protein_coding | protein_coding | ENST00000265986 | 25 | 122393 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00663 | 0.993 | 125694 | 0 | 52 | 125746 | 0.000207 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.08 | 396 | 531 | 0.746 | 0.0000268 | 6722 |
Missense in Polyphen | 108 | 183.07 | 0.58995 | 2350 | ||
Synonymous | 0.791 | 172 | 186 | 0.926 | 0.00000952 | 1834 |
Loss of Function | 5.17 | 16 | 58.7 | 0.273 | 0.00000301 | 751 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000499 | 0.000489 |
Ashkenazi Jewish | 0.000400 | 0.000397 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.000326 | 0.000323 |
European (Non-Finnish) | 0.000213 | 0.000211 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000134 | 0.000131 |
Other | 0.000348 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Plays a role in the cellular breakdown of insulin, IAPP, glucagon, bradykinin, kallidin and other peptides, and thereby plays a role in intercellular peptide signaling. Degrades amyloid formed by APP and IAPP. May play a role in the degradation and clearance of naturally secreted amyloid beta-protein by neurons and microglia. {ECO:0000269|PubMed:10684867, ECO:0000269|PubMed:17613531, ECO:0000269|PubMed:18986166}.;
- Pathway
- Alzheimer,s disease - Homo sapiens (human);Alzheimers Disease;Post-translational protein modification;Metabolism of proteins;Peroxisomal protein import;Ub-specific processing proteases;Deubiquitination
(Consensus)
Recessive Scores
- pRec
- 0.443
Intolerance Scores
- loftool
- 0.797
- rvis_EVS
- -1.53
- rvis_percentile_EVS
- 3.39
Haploinsufficiency Scores
- pHI
- 0.838
- hipred
- Y
- hipred_score
- 0.706
- ghis
- 0.640
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.831
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ide
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); skeleton phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); craniofacial phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan);
Zebrafish Information Network
- Gene name
- ide
- Affected structure
- pancreatic B cell
- Phenotype tag
- abnormal
- Phenotype quality
- decreased area
Gene ontology
- Biological process
- proteolysis;protein targeting to peroxisome;insulin receptor signaling pathway;determination of adult lifespan;bradykinin catabolic process;ubiquitin recycling;positive regulation of protein oligomerization;hormone catabolic process;positive regulation of protein catabolic process;negative regulation of proteolysis;viral entry into host cell;amyloid-beta metabolic process;protein homooligomerization;protein homotetramerization;protein heterooligomerization;proteolysis involved in cellular protein catabolic process;amyloid-beta clearance;insulin metabolic process;insulin catabolic process;regulation of aerobic respiration
- Cellular component
- extracellular space;nucleus;cytoplasm;mitochondrion;peroxisome;peroxisomal matrix;cytosol;external side of plasma membrane;cell surface;basolateral plasma membrane;cytosolic proteasome complex
- Molecular function
- amyloid-beta binding;virus receptor activity;metalloendopeptidase activity;signaling receptor binding;protein binding;ATP binding;zinc ion binding;ATPase activity;beta-endorphin binding;peptide binding;protein homodimerization activity;insulin binding;ubiquitin-dependent protein binding